Kouvaras E, Asprodini E K, Asouchidou I, Vasilaki A, Kilindris T, Michaloudis D, Koukoutianou I, Papatheodoropoulos C, Kostopoulos G
Laboratory of Pharmacology, School of Medicine, University of Thessaly, Faculty of Health Sciences, 22 Papakiriazi Street, 41222 Larissa, Greece.
Neuropharmacology. 2008 Dec;55(7):1172-82. doi: 10.1016/j.neuropharm.2008.07.025. Epub 2008 Jul 26.
The effect of in vivo fentanyl treatment on synaptic transmission was studied in the CA1 area of the rat hippocampus. Animals were treated either with saline or fentanyl (4 x 80 microg/kg, s.c./15 min). Intracellular in vitro recordings were obtained, 24 h after treatment, from CA1 pyramidal neurons. No difference in pyramidal neuron basic membrane properties or postsynaptic membrane excitability was observed between neurons from saline- and fentanyl-treated animals. The peak amplitude of fast (f-) and slow (s-) components of IPSPs elicited in standard ACSF and the peak amplitude and rate of rise of isolated f- and s-IPSPs elicited in the presence of antagonists (CNQX, 10 microM; AP-5, 10 microM; CGP 55845, 1 microM; and bicuculline methochloride, 10 microM), in response to various stimulus intensities, was smaller in fentanyl-treated animals. Conversely, the rising slope of excitatory responses was similar in neurons from saline- and fentanyl-treated animals. Furthermore, in fentanyl-treated animals, lower stimulus strengths were required to elicit subthreshold excitatory responses of the same amplitude suggesting that acute exposure to fentanyl increases susceptibility of pyramidal neurons to presynaptic stimulation. GABA immunohistochemistry revealed lower GABA content in processes and neuronal somata suggesting diminished GABA release onto pyramidal neurons. We conclude that acute in vivo exposure to fentanyl is sufficient to induce long-lasting reduction in GABA-mediated transmission, rather, than enhanced excitatory transmission or modulation of the intrinsic excitability of pyramidal neurons. These findings provide evidence regarding the mechanisms involved in the early stages of tolerance development towards the analgesic effects of opioids.
在大鼠海马体的CA1区研究了体内芬太尼治疗对突触传递的影响。动物分别接受生理盐水或芬太尼(4×80微克/千克,皮下注射/15分钟)治疗。治疗24小时后,从CA1锥体神经元进行细胞内体外记录。在接受生理盐水和芬太尼治疗的动物的神经元之间,未观察到锥体神经元基本膜特性或突触后膜兴奋性的差异。在标准人工脑脊液中诱发的抑制性突触后电位(IPSP)的快速(f-)和慢速(s-)成分的峰值幅度,以及在拮抗剂(CNQX,10微摩尔;AP-5,10微摩尔;CGP 55845,1微摩尔;和甲氯异丁嗪,10微摩尔)存在的情况下诱发的分离的f-和s-IPSP的峰值幅度和上升速率,在芬太尼治疗的动物中对各种刺激强度的反应较小。相反,在接受生理盐水和芬太尼治疗的动物的神经元中,兴奋性反应的上升斜率相似。此外,在芬太尼治疗的动物中,诱发相同幅度的阈下兴奋性反应所需的刺激强度较低,这表明急性暴露于芬太尼会增加锥体神经元对突触前刺激的敏感性。GABA免疫组织化学显示,在神经突和神经元胞体中GABA含量较低,表明释放到锥体神经元上的GABA减少。我们得出结论,急性体内暴露于芬太尼足以诱导GABA介导的传递长期减少,而不是增强兴奋性传递或调节锥体神经元的内在兴奋性。这些发现为阿片类药物镇痛作用耐受性发展早期阶段所涉及的机制提供了证据。